Skip to Main Content

Advertisement

Skip Nav Destination

CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma

Blood (2018) 132 (6): 577–586.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement